Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPD

Summary

The purpose of this study is: 1.- to assess the safety and tolerability of autologous adipose derived stem cells (aADSC) administered intravenously in patients with chronic obstructive pulmonary disease, and 2.- to assess if this therapy results in less decrease of lung function parameters (FEV1, FEV1/FVC and 6 min walking distance) compared with a control baseline of 6 weeks. Patients will be followed up for 12 months after the therapy.

Timeline

Start

2013-10-10

Primary completion

2018-10-29

Completion

2018-10-29

Outcome

Outcome not reported

Stopped (Enrollment): “Poor enrollment”

Drugs

Indications